How to anticipate eCOA complexities in multi-year studies & develop best practice to support sites?
Using eCOA solutions can bring its own set of challenges.
This workshop held by Kayentis in 2020 aimed at discussing the hurdles that arise when using eCOA solutions in long lasting clinical trials, essentially from the sites’ perspective.
What are the main issues encountered on a day-to-day basis? And how can industry stakeholders better understand issues faced by site staff and offer solutions to keep them engaged?
We warmly thank all the participants for their active contribution to this session.
Subscribe to our newsletter
You may also like
About the author
Marc Chaperon
Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.
